71 – 80 of 247
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
(
- Contribution to journal › Article
-
Mark
Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis
(
- Contribution to journal › Article
-
Mark
Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study.
(
- Contribution to journal › Article
-
Mark
Trends in the first decade of 21st century healthcare utilisation in a rheumatoid arthritis cohort compared with the general population.
(
- Contribution to journal › Article
-
Mark
Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis.
(
- Contribution to journal › Letter
-
Mark
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
(
- Contribution to journal › Article
- 2012
-
Mark
Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study
(
- Contribution to journal › Article
-
Mark
Association between genetic variants in the tumour necrosis factor/lymphotoxin alpha/lymphotoxin beta locus and primary Sjogren's syndrome in Scandinavian samples
(
- Contribution to journal › Article
-
Mark
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
(
- Contribution to journal › Article